(310 days)
Not Found
No
The device description and performance studies focus on mechanical properties and biocompatibility, with no mention of software, algorithms, or data processing that would indicate AI/ML.
No
The device is designed to retrieve foreign bodies or resected tissue, which is a diagnostic or interventional procedure, not a therapeutic treatment.
No
Explanation: The device is described as grasping forceps used to retrieve foreign bodies or resected tissue. Its intended use is mechanical removal, not diagnostic assessment like imaging, chemical analysis, or physiological measurement.
No
The device description explicitly details physical components (Handle, Insertion portion, Distal end, Sheath portion, Body, Slider, Grasping jaws) and describes a mechanical action (operating the Handle to grasp). This indicates a hardware device, not software only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to physically retrieve foreign bodies or resected tissue from the nasal lumens and airway anatomy. This is a mechanical action performed in vivo (within the body), not a test performed in vitro (outside the body) on a sample to diagnose a condition.
- Device Description: The device is described as grasping forceps, a tool for physically manipulating objects. It does not involve the analysis of biological samples for diagnostic purposes.
- Lack of IVD Characteristics: There is no mention of analyzing samples, detecting analytes, or providing diagnostic information based on biological or chemical tests.
Therefore, this device falls under the category of a surgical or endoscopic accessory used for retrieval, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
Single Use Grasping Forceps FG-214P, FG-804L
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies or resected tissue from the nasal lumens and airway anatomy (including nasopharynx and trachea).
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies or resected tissue from the airways and tracheobronchial tree.
Single Use Grasping Forceps FG-226C, FG-232L
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies or resected tissue from the airways and tracheobronchial tree.
Single Use Grasping Forceps FG-220P
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies from the nasal lumens and airway anatomy (including nasopharynx and trachea).
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies from the airways and tracheobronchial tree.
Product codes (comma separated list FDA assigned to the subject device)
EOQ, EOB
Device Description
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies or resected tissue from the airways and tracheobronchial tree.
FG-214P and FG-804L have been also designed to be used with an Olympus endoscope to retrieve foreign bodies from the nasal lumens and airway anatomy (including nasopharynx and trachea).
The subject device is single-use grasping forceps sterilized by Ethylene Oxide.
The subject device consists of the Handle and the Insertion portion. The Insertion portion consists of the Distal end and the Sheath portion. The Handle consists of the Body and the Slider.
The subject device, after inserted into an endoscope from the Distal end, is used to grasp a foreign body or resected tissue with a pair of forceps (the Grasping jaws) at the Distal end by operating the Handle. The foreign body or the resected tissue is retrieved by removing the subject device together with the endoscope from the patient.
FG-220P:
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies from the airways and tracheobronchial tree.
This instrument has also been designed to be used with an Olympus endoscope to retrieve foreign bodies from the nasal lumens and airway anatomy (including nasopharynx and trachea).
The subject device is single-use grasping forceps sterilized by Ethylene Oxide.
The subject device consists of a Handle and an Insertion portion. The Insertion portion consists of the Distal end and the Sheath portion. The Handle consists of the Body and the Slider.
The subject device, after inserted into an endoscope from the Distal end, is used to grasp a foreign body with a pair of forceps (the Grasping jaws) at the Distal end by operating the Handle. The foreign body is retrieved by removing the subject device together with the endoscope from the patient.
Principle of Operation:
The subject device retrieves foreign bodies or resected tissue. The device interacts with the patient as follows.
The subject device is inserted into the biopsy valve of an endoscope while its grasping jaws closed by pulling the slider. It is advanced until the distal end of the insertion portion appears within the endoscopic field of view.
To grasp a foreign body or resected tissue, the slider is pushed to open the grasping jaws. Pull the slider to grasp the foreign body or the resected tissue.
The subject device is retrieved from the patient with the endoscope to remove the foreign body or the resected tissue.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
nasal lumens and airway anatomy (including nasopharynx and trachea), airways and tracheobronchial tree
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Prescription Use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
- Sterilization/Shelf life testing: Sterilization/shelf life testing were conducted in accordance with the FDA's Guidance for Industry and Food and Drug Administration Staff, "Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile". Accelerated aging test was conducted in accordance with ASTM F1980-16, the standard guide for accelerated aging of sterile barrier systems for medical devices. The real-time aging test for three-years will be performed to demonstrate longer stability and support the results of the accelerated aging test.
- Biocompatibility testing: Biocompatibility testing were conducted in accordance with the FDA's Guidance for Industry and Food and Drug Administration Staff, Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process". The biocompatibility testing included the following tests: Cytotoxicity Study Using the Colony Assay, Intracutaneous Study in Rabbits, Guinea Pig Maximization Sensitization Test, Acute Systemic Toxicity Study in Mice.
- Performance testing - Bench: Bench testing as listed below were conducted to ensure that the subject device performs as intended and meet design specifications.
- Insertability into the endoscope
- Open and close of the grasping jaws
- Grasping performance
- Withdrawal property from the endoscope
- Device reliability
- Burr and/or edge of the insertion portion
- Strength of junction
- Breakage tolerance of the forceps
- Risk management: Risk management was performed in accordance with ISO 14971:2007. The design verification tests and their acceptance criteria were identified and performed as a result of this risk management.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 874.4680 Bronchoscope (flexible or rigid) and accessories.
(a)
Identification. A bronchoscope (flexible or rigid) and accessories is a tubular endoscopic device with any of a group of accessory devices which attach to the bronchoscope and is intended to examine or treat the larynx and tracheobronchial tree. It is typically used with a fiberoptic light source and carrier to provide illumination. The device is made of materials such as stainless steel or flexible plastic. This generic type of device includes the rigid ventilating bronchoscope, rigid nonventilating bronchoscope, nonrigid bronchoscope, laryngeal-bronchial telescope, flexible foreign body claw, bronchoscope tubing, flexible biopsy forceps, rigid biopsy curette, flexible biopsy brush, rigid biopsy forceps, flexible biopsy curette, and rigid bronchoscope aspirating tube, but excludes the fiberoptic light source and carrier.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
December 17, 2020
Olympus Medical Systems Corp. % Sheri Musgnung Regulatory Affairs Manager Olympus Corporation of the Americas 3500 Corporate Parkway PO Box 610 Center Valley, Pennsylvania 18034-0610
Re: K200342
Trade/Device Name: Single Use Grasping Forceps FG-214P, Single Use Grasping Forceps FG-220P, Single Use Grasping Forceps FG-226C, Single Use Grasping Forceps FG-232L, Single Use Grasping Forceps FG-804L Regulation Number: 21 CFR 874.4680 Regulation Name: Bronchoscope (Flexible Or Rigid) And Accessories Regulatory Class: Class II Product Code: EOQ, EOB Dated: November 18, 2020 Received: November 18, 2020
Dear Sheri Musgnung:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
for Malvina B. Eydelman, M.D. Director OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K200342
Device Name
Single Use Grasping Forceps FG-214P, FG-804L
Indications for Use (Describe)
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies or resected tissue from the nasal lumens and airway anatomy (including nasopharynx and trachea).
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies or resected tissue from the airways and tracheobronchial tree.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
3
Indications for Use
510(k) Number (if known) K200342
Device Name
Single Use Grasping Forceps FG-226C, FG-232L
Indications for Use (Describe)
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies or resected tissue from the airways and tracheobronchial tree.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
Indications for Use
510(k) Number (if known) K200342
Device Name
Single Use Grasping Forceps FG-220P
Indications for Use (Describe)
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies from the nasal lumens and airway anatomy (including nasopharynx and trachea).
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies from the airways and tracheobronchial tree.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
5
Image /page/5/Picture/0 description: The image shows the word "OLYMPUS" in large, bold, blue letters. The letters are slightly shadowed, giving them a three-dimensional appearance. A registered trademark symbol is located to the right of the word.
December 17, 2020 K200342
510(k) Summary
1. GENERAL INFORMATION
■ 510(k) Submitter: OLYMPUS MEDICAL SYSTEMS CORP. 2951 Ishikawa-cho, Hachioji-shi, Tokyo, 192-8507, Japan
- Contact Person: Sheri L. Musgnung Olympus Corporation of the Americas 3500 Corporate Parkway PO Box 610 Center Valley, PA 18034-0610, USA Phone: 484-896-3147 Fax: 484-896-7128 Email: sheri.musgnung@olympus.com
- I Manufacturing site: Aomori Olympus Co., Ltd. 2-248-1 Okkonoki, Kuroishi-shi, Aomori 036-0357, Japan
2. DEVICE IDENTIFICATION
| Device Name | Model Name | Regulation Number/Name | Product Code |
|---|---|---|---|
| Single Use | |||
| Grasping | |||
| Forceps | |||
| FG-214P | FG-214P | 874.4680 Bronchoscope (flexible | |
| or rigid) and | |||
| accessories | |||
| 876.4760 Nasopharyngoscope | |||
| (flexible or rigid) and | |||
| accessories | EOQ | ||
| EOB | |||
| Single Use | |||
| Grasping | |||
| Forceps | |||
| FG-220P | FG-220P | 874.4680 Bronchoscope (flexible | |
| or rigid) and | |||
| accessories | |||
| 874.4760 Nasopharyngoscope | |||
| (flexible or rigid) and | |||
| accessories | EOQ | ||
| EOB | |||
| Single Use | |||
| Grasping | |||
| Forceps | |||
| FG-226C | FG-226C | 874.4680 Bronchoscope (flexible | |
| or rigid) and | |||
| accessories | EOQ | ||
| Single Use | FG-232L | 874.4680 Bronchoscope (flexible | EOQ |
6
Image /page/6/Picture/0 description: The image shows the word "OLYMPUS" in a bold, sans-serif font. The letters are a dark blue color. There is a registered trademark symbol to the right of the letter "S".
| Grasping
Forceps
FG-232L | | or rigid) and
accessories | |
|----------------------------------------------|---------|-----------------------------------------------------------------------------------------------------------------------------------------|------------|
| Single Use
Grasping
Forceps
FG-804L | FG-804L | 874.4680 Bronchoscope (flexible
or rigid) and
accessories
874.4760 Nasopharyngoscope
(flexible or rigid) and
accessories | EOQ
EOB |
- Common Name: Grasping Forceps
- Class II ■ Regulatory Class:
- Classification Panel: Ear, Nose and Throat
3. PREDICATE DEVICE
■ Predicate devices
| Device name | 510(k) Submitter | 510(k) No. |
|---|---|---|
| Olympus FG Series Reusable | ||
| Grasping Forceps | ||
| (FG-14P-1/FG-26C-1/FG-20P-1/FG-3 | ||
| 2L-1/FG-4L-1) | OLYMPUS MEDICAL | |
| SYSTEMS CORP. | K962533 | |
| Grasping Forceps FG-53SX-1 | OLYMPUS MEDICAL | |
| SYSTEMS CORP. | K013591 |
4. DEVICE DESCRIPTION
■ General Description of the subject device FG-214P, FG-226C, FG-232L, FG-804L
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies or resected tissue from the airways and tracheobronchial tree.
FG-214P and FG-804L have been also designed to be used with an Olympus endoscope to retrieve foreign bodies from the nasal lumens and airway anatomy (including nasopharynx and trachea).
7
Image /page/7/Picture/0 description: The image shows the word "OLYMPUS" in large, bold, blue letters. The letters are closely spaced and have a slightly three-dimensional appearance. There is a registered trademark symbol to the right of the letter "S". A thin, horizontal, yellow line is located beneath the word.
The subject device is single-use grasping forceps sterilized by Ethylene Oxide.
The subject device consists of the Handle and the Insertion portion. The Insertion portion consists of the Distal end and the Sheath portion. The Handle consists of the Body and the Slider.
The subject device, after inserted into an endoscope from the Distal end, is used to grasp a foreign body or resected tissue with a pair of forceps (the Grasping jaws) at the Distal end by operating the Handle. The foreign body or the resected tissue is retrieved by removing the subject device together with the endoscope from the patient.
FG-220P
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies from the airways and tracheobronchial tree.
This instrument has also been designed to be used with an Olympus endoscope to retrieve foreign bodies from the nasal lumens and airway anatomy (including nasopharynx and trachea).
The subject device is single-use grasping forceps sterilized by Ethylene Oxide.
The subject device consists of a Handle and an Insertion portion. The Insertion portion consists of the Distal end and the Sheath portion. The Handle consists of the Body and the Slider.
The subject device, after inserted into an endoscope from the Distal end, is used to grasp a foreign body with a pair of forceps (the Grasping jaws) at the Distal end by operating the Handle. The foreign body is retrieved by removing the subject device together with the endoscope from the patient.
Principle of Operation
The subject device retrieves foreign bodies or resected tissue. The device interacts with the patient as follows.
The subject device is inserted into the biopsy valve of an endoscope while its grasping jaws closed by pulling the slider. It is advanced until the distal end of the insertion portion appears within the endoscopic field of view.
To grasp a foreign body or resected tissue, the slider is pushed to open the grasping jaws. Pull the slider to grasp the foreign body or the resected tissue.
The subject device is retrieved from the patient with the endoscope to remove the
8
Image /page/8/Picture/0 description: The image shows the word "OLYMPUS" in large, bold, blue letters. The font is sans-serif and the letters are closely spaced together. There is a registered trademark symbol to the right of the letter "S". A gold line is underneath the word.
foreign body or the resected tissue.
5. INDICATIONS FOR USE
Single Use Grasping Forceps FG-214P, FG-804L
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies or resected tissue from the nasal lumens and airway anatomy (including nasopharynx and trachea).
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies or resected tissue from the airways and tracheobronchial tree.
Single Use Grasping Forceps FG-226C, FG-232L
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies or resected tissue from the airways and tracheobronchial tree.
Single Use Grasping Forceps FG-220P
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies from the nasal lumens and airway anatomy (including nasopharynx and trachea).
This instrument has been designed to be used with an Olympus endoscope to retrieve foreign bodies from the airways and tracheobronchial tree.
9
Image /page/9/Picture/0 description: The image shows the word "OLYMPUS" in large, bold, blue letters. The letters are all capitalized and have a slightly rounded appearance. A registered trademark symbol is present to the right of the letter "S".
6. COMPARISON OF TECHNOLOGY CHARACTERISTICS WITH THE PREDICATE DEVICES
The Single Use Grasping Forceps has the same technological characteristics and design as the predicate devices except for the following new features:
- ETO sterilized -
- -Single use
- Handle design -
- Material -
All other technological characteristics of both the subject and predicate devices are the same as the predicate devices.
Validation from non-clinical testing demonstrated that these technological features do not raise any new issues of safety or effectiveness compared to the predicate devices.
7 PERFORMANCE DATA
The following performance data were provided in support of the substantial equivalence determination.
1) Sterilization/Shelf life testing
Sterilization/shelf life testing were conducted in accordance with the FDA's Guidance for Industry and Food and Drug Administration Staff, "Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile".
Accelerated aging test was conducted in accordance with ASTM F1980-16, the standard guide for accelerated aging of sterile barrier systems for medical devices. The real-time aging test for three-years will be performed to demonstrate longer stability and support the results of the accelerated aging test.
2) Biocompatibility testing
Biocompatibility testing were conducted in accordance with the FDA's Guidance for Industry and Food and Drug Administration Staff, Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process". The biocompatibility testing included the following tests:
- Cytotoxicity Study Using the Colony Assay i
- Intracutaneous Study in Rabbits ।
- Guinea Pig Maximization Sensitization Test ।
10
Image /page/10/Picture/0 description: The image shows the word "OLYMPUS" in large, bold, blue letters. The font is sans-serif and the letters are closely spaced. There is a registered trademark symbol to the right of the letter "S".
- Acute Systemic Toxicity Study in Mice -
3) Performance testing - Bench
Bench testing as listed below were conducted to ensure that the subject device performs as intended and meet design specifications.
- Insertability into the endoscope
- Open and close of the grasping jaws
- Grasping performance
- Withdrawal property from the endoscope
- Device reliability
- Burr and/or edge of the insertion portion
- Strength of junction
- Breakage tolerance of the forceps
4) Risk management
Risk management was performed in accordance with ISO 14971:2007. The design verification tests and their acceptance criteria were identified and performed as a result of this risk management.
8. CONCLUSIONS
Based on the indications for use, technological characteristics, performance testing and technological comparison to the predicate devices, the Single Use Grasping Forceps do not raise different questions of safety and effectiveness and are substantially equivalent to the predicate devices in terms of safety, effectiveness and performance.